[6] [7] Tranexamic acid is about 10 times more potent in vitro than aminocaproic acid, binding more strongly to both the high and low-affinity binding sites of plasminogen
Dosages can vary depending on the health concern
In addition, preventing the relapse and recurrence of clinically significant symptoms is essential for new treatment approaches and/or the identification of markers of response to established treatments
Nose-to-brain pathway was found to be efficient in the delivery of bioactive peptides and growth factors, such as exendin-4, leptin, orexin, vasoactive intestinal peptide (VIP), galanin-like peptide (GALP), interferon-, insulin-like growth factor (IGF), nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and basic fibroblast growth factor (bFGF) (Kamei et al., 2017)